No recent analyst price targets found for PSYGF.
Latest News for PSYGF
Psyence BioMed Welcomes U.S. Administration's Latest Action to Accelerate Ibogaine Development
Company says growing federal commitment to ibogaine aligns directly with the pharmaceutical development and manufacturing platform Psyence BioMed has built Company says growing federal commitment to ibogaine aligns directly with the pharmaceutical development and manufacturing platform Psyence BioMed has built
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for PSYGF.
Senate Trading
No Senate trades found for PSYGF.
U.S. House Trading
No House trades found for PSYGF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.